Insider Transactions in Q2 2025 at Arcutis Biotherapeutics, Inc. (ARQT)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 28
2025
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
1,800
-0.88%
|
$23,400
$13.78 P/Share
|
|
May 22
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
2,520
+10.06%
|
$32,760
$13.65 P/Share
|
|
May 21
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
2,520
+11.18%
|
$32,760
$13.66 P/Share
|
|
May 19
2025
|
Larry Todd Edwards Officer |
SELL
Open market or private sale
|
Direct |
7,451
-3.91%
|
$104,314
$14.07 P/Share
|
|
May 15
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
2,520
+12.59%
|
$32,760
$13.62 P/Share
|
|
May 14
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
6,300
+29.61%
|
$81,900
$13.76 P/Share
|
|
May 13
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
2,374
+21.49%
|
$30,862
$13.76 P/Share
|
|
May 09
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
6,300
+50.0%
|
$81,900
$13.6 P/Share
|
|
May 08
2025
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
3,871
-3.24%
|
$50,323
$13.59 P/Share
|
|
May 06
2025
|
Latha Vairavan SVP Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+23.5%
|
-
|
|
May 02
2025
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
2,597
-2.13%
|
$38,955
$15.19 P/Share
|
|
May 02
2025
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
11,448
-1.24%
|
$171,720
$15.19 P/Share
|
|
May 02
2025
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
5,030
-2.4%
|
$75,450
$15.2 P/Share
|
|
May 01
2025
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
10,000
-8.2%
|
$140,000
$14.64 P/Share
|
|
Apr 02
2025
|
David Joseph Topper Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,600
-4.99%
|
$144,000
$15.8 P/Share
|
|
Apr 01
2025
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
10,000
-7.58%
|
$150,000
$15.12 P/Share
|